|
|
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
|
1R01CA180277-01
|
$275,552
|
$275,552
|
Li, Xin
|
NEW YORK UNIVERSITY
|
|
|
(PQB5) Does the timing of Pten and Rb1 mutation affect prostate cancer phenotypes
|
1R21CA179907-01
|
$221,589
|
$221,589
|
GOODRICH, DAVID
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
(PQB6) Accurate Comparative Genome-wide Analysis of Primary Tumors and Metastases
|
1R21CA180016-01
|
$206,190
|
$103,095
|
Wotton, David
|
UNIVERSITY OF VIRGINIA
|
|
|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
1R21CA179981-01
|
$197,055
|
$98,528
|
Henry, Michael
|
UNIVERSITY OF IOWA
|
|
|
(PQD-1) NF-kB activation and enzalutamide therapy in metastatic castration resist
|
1R21CA179970-01
|
$200,970
|
$200,970
|
GAO, ALLEN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
1) Computing Services for DCP; 2) Prostate, Lung, Colorectal, and Ovarian (PLCO)
|
N01CA130008
|
$4,401,871
|
$1,100,468
|
UNKNOWN, UNKNOWN
|
INFORMATION MANAGEMENT SERVICES, INC.
|
|
|
7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co
|
1R13CA171707-01
|
$20,000
|
$10,000
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
A diagnostic test for the detection of prostate cancer from urine DNA
|
1R43CA165444-01A1
|
$287,585
|
$287,585
|
FREIJE, DIHA
|
EUCLID DIAGNOSTICS, LLC
|
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
$82,302
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Microchip with Thermally Responsive Polymers for Capture and Recovery of CTCs
|
1R43CA180482-01
|
$200,465
|
$200,465
|
Garcia, Mitch
|
CYTOLUMINA TECHNOLOGIES CORPORATION, INC
|
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$101,345
|
$50,672
|
Kelly, Kathleen
|
CCR (NCI)
|
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-03
|
$1,666,218
|
$466,541
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
|
A Network Analytic Approach to Modeling Variation in Prostate Cancer Care
|
5K07CA151910-03
|
$156,570
|
$156,570
|
Pollack, Craig
|
JOHNS HOPKINS UNIVERSITY
|
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
1U01CA166894-01A1
|
$369,879
|
$369,879
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
A new regulator for Wnt/beta-catenin signaling and prostate tumorigenesis
|
5R01CA151623-03
|
$315,839
|
$315,839
|
SUN, ZIJIE
|
STANFORD UNIVERSITY
|
|
|
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC
|
5R01CA138583-03
|
$263,318
|
$263,318
|
HAMBURGER, ANNE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
A novel mouse prostate carcinogenesis model for dietary cancer prevention researc
|
5R03CA159361-02
|
$72,850
|
$72,850
|
YANG, CHUNG
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
|
|
A novel strategy to identify prostate cancer biomarkers for patient management
|
1R01CA172603-01A1
|
$319,550
|
$319,550
|
HUANG, JIAOTI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-03
|
$274,795
|
$274,795
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
|
A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence
|
5R01CA134493-05
|
$634,348
|
$634,348
|
Frangioni, John
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
A Systems Biology Approach to the Development of Cancer Biomarkers
|
5U01CA111275-09
|
$634,323
|
$634,323
|
CHINNAIYAN, ARUL
|
UNIVERSITY OF MICHIGAN
|
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-15
|
$699,208
|
$139,842
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment
|
3R01CA164388-02S1
|
$79,724
|
$79,724
|
Zeng, Gang
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment
|
5R01CA164388-02
|
$300,377
|
$300,377
|
Zeng, Gang
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$375
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$216,506
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-04
|
$304,764
|
$213,335
|
Mahajan, Nupam
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-03
|
$1,055,550
|
$105,555
|
Sloan, Jeff
|
MAYO CLINIC ROCHESTER
|
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$103,603
|
$20,721
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
|
Adaptable Polymer Micelles for Tumor Targeting
|
5R01CA129287-04
|
$281,401
|
$140,701
|
PARK, KINAM
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
|
Addressing Prostate Cancer Information Disparities with eHealth Technology
|
1R21CA178296-01
|
$241,423
|
$241,423
|
ALLEN, JENNIFER
|
TUFTS UNIVERSITY BOSTON
|
|
|
Adiposity and Outcomes of Clinically Localized Prostate Cancer
|
5R01CA129140-05
|
$518,785
|
$518,785
|
Freeman, Vincent
|
UNIVERSITY OF ILLINOIS
|
|
|
Advanced Development of An Integrated CTC Enrichment Technology
|
5R33CA157396-03
|
$218,574
|
$218,574
|
TSENG, HSIAN-RONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Advanced PET/CT Imaging for Improving Clincail Trials
|
5U01CA148131-04
|
$532,690
|
$266,345
|
KINAHAN, PAUL
|
UNIVERSITY OF WASHINGTON
|
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-02
|
$382,754
|
$382,754
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Advancing Clinical Trails in Coastal North Carolina
|
1U10CA176852-01
|
$532,663
|
$90,553
|
MAGUIRE, PATRICK
|
NEW HANOVER REGIONAL MEDICAL CENTER
|
|
|
Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors
|
5R01CA127727-05
|
$295,150
|
$295,150
|
GARCIA-BLANCO, MARIANO
|
DUKE UNIVERSITY
|
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
$2,161,623
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
AMH and prostate cancer risk in PLCO
|
ZIA CP010180-10675
|
$24,882
|
$24,882
|
Cook, Michael
|
DCEG (NCI)
|
|
|
Amoeboid Membrane Dynamics in Prostate Cancer
|
5R01CA143777-04
|
$372,685
|
$372,685
|
FREEMAN, MICHAEL
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
An androgen-regulated cytokine network controls prostate apoptosis
|
5R01CA151753-03
|
$40,431
|
$40,431
|
KROLEWSKI, JOHN
|
UNIVERSITY OF ROCHESTER
|
|
|
An integrated approach to dissect the functional network of large non-coding RNA
|
1K99CA175290-01
|
$112,476
|
$112,476
|
Chen, Yiwen
|
DANA-FARBER CANCER INST
|
|
|
Analyses of human T regulatory cells
|
ZIA BC 010973
|
$256,513
|
$76,954
|
Tsang, Kwong
|
CCR (NCI)
|
|
|
Analysis of Radiobiological Material from Exposed Human Subjects
|
ZIA CP010132-10623
|
$6,907
|
$6,907
|
Little, Mark
|
DCEG (NCI)
|
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
1P01CA163227-01A1
|
$2,183,516
|
$2,183,516
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Androgen Receptor Function in Prostate Cancer
|
5R01CA086072-11
|
$214,812
|
$214,812
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Androgen Receptor Regulation by Phosphorylation
|
5R00CA135592-05
|
$227,037
|
$227,037
|
Chen, Shaoyong
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Androgen Receptor Targeted Vaccines for Prostate Cancer
|
5R01CA142608-04
|
$332,331
|
$332,331
|
MCNEEL, DOUGLAS
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Androgen Signaling and Coactivator Regulation in PCA
|
5R01CA150197-04
|
$290,814
|
$290,814
|
Kung, Hsing-Jien
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Total relevant funding to Prostate for this search: $255,612,921
|
